Ticketmaster Pronounces Plan to Evaluation Coronavirus Vaccine Standing Earlier than Concert events
Following news that a pharmonavirus vaccine with a 90% efficacy rate is in development in an initial study by pharmaceutical company Pfizer, Ticketmaster has announced a plan to review concert goers' vaccine status before attending concerts, reports Billboard.
The proposed system involves using Ticketmaster's digital ticket app, which is used to collect information from third-party health information companies (such as IBM's Digital Health Pass or CLEAR Health Pass), as well as test and vaccine distributors (such as Labcorp or CVS Minute Clinic). The goal is to ensure safety by checking fans' vaccination status or whether they have tested negative for COVID-19 within a period of 24 to 72 hours.
Ticketmaster has also developed digital ticketing linked to the identity of ticket buyers, as well as a SmartEvent system to enforce social distancing, late entry and contact tracing. Organizers can set specific prevention protocols, including hygiene, mask compliance, and social distancing. The company has made it clear that all third-party health information is stored as part of HIPPA compliance and not with Ticketmaster.
A specific timeline for widespread availability of the vaccine, which is reported to be available free of charge to the American public, is currently unclear. When Ticketmaster President Mark Yovich reached for a comment, he told Pitchfork:
We anticipate that there will be many third-party healthcare providers doing the verification – whether it's a vaccine, test, or any other verification and approval method – that can then be linked via a digital ticket so that everyone who takes part in the event is checked. Ticketmaster's goal is to provide enough flexibility and options so that venues and fans have multiple avenues to return to events and is working to create integrations with our API and leading digital ticketing technology based around the top solutions to tap into what is environmentally friendly. illuminated by officials and requested by customers.
Pitchfork has also reached out to Live Nation Entertainment representatives to inquire about possible fees related to Ticketmaster's COVID-19 vaccine status policy.
Scientists in Germany recently published the results of their experiment on the transmission of the coronavirus at concerts. The study, which was not peer-reviewed, found that the risk of coronavirus spreading at indoor concerts is “low to very low” as long as concert goers follow hygiene protocols and the venue has good ventilation and capacity limits.